Details for Patent: 10,179,119
✉ Email this page to a colleague
Which drugs does patent 10,179,119 protect, and when does it expire?
Patent 10,179,119 protects HETLIOZ and HETLIOZ LQ and is included in two NDAs.
This patent has twenty-seven patent family members in seventeen countries.
Summary for Patent: 10,179,119
| Title: | Method of treatment |
| Abstract: | Embodiments of the invention relate to the treatment of sleep disturbances in individuals with Smith-Magenis Syndrome (SMS). |
| Inventor(s): | Lavedan; Christian (Potomac, MD), Polymeropoulos; Mihael H. (Potomac, MD) |
| Assignee: | VANDA PHARMACEUTICALS INC. (Washington, DC) |
| Application Number: | 15/326,934 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,179,119
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON | ⤷ Try a Trial | |||
| Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NIGHTTIME SLEEP DISTURBANCES IN SMITH-MAGENIS SYNDROME BY ADMINISTERING TASIMELTEON | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,179,119
| PCT Information | |||
| PCT Filed | August 29, 2015 | PCT Application Number: | PCT/US2015/047610 |
| PCT Publication Date: | March 10, 2016 | PCT Publication Number: | WO2016/036619 |
International Family Members for US Patent 10,179,119
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015312252 | ⤷ Try a Trial | |||
| Australia | 2020239640 | ⤷ Try a Trial | |||
| Brazil | 112017003644 | ⤷ Try a Trial | |||
| Canada | 2957588 | ⤷ Try a Trial | |||
| Canada | 3124872 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
